脑干脱极化诱导的致命性呼吸暂停与功能增强相关SCN1AL263V被通道阻塞阻止
Nico A Jansen1, Sandrine Cestèle2,3, Silvia Sanchez Marco4
1Department of Human Genetics, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands.
概括
一种罕见的SCN1A基因突变导致了危及生命的婴儿呼吸暂停,与大脑干脱极化有关. 通道阻断剂成功地治疗了小鼠的呼吸暂停,并减少了患者的事件.
科学领域:
- 遗传学和神经学 遗传学和神经学
- 分子生物学分子生物学
- 儿科医学 儿科医学
背景情况:
- 婴儿呼吸暂停,虽然通常是良性的,但可能是危及生命的.
- 该SCN1A基因编码Nav1.1通道,对于神经元功能至关重要.
- 家族性半性偏头痛3型与异性SCN1A突变有关.
研究的目的:
- 研究SCN1A (L263V) 突变在婴儿严重呼吸暂停事件中的作用.
- 确定SCN1A(L263V) 突变的功能后果.
- 评估通道阻断剂对SCN1A相关性呼吸暂停的治疗潜力.
主要方法:
- 一个婴儿患有同卵性SCN1A (L263V) 突变和呼吸暂停事件的病例报告.
- 利用一个Scn1a(L263V) 敲入小鼠模型来研究呼吸暂停.
- 在表达突变Nav1.1通道的HEK293细胞中进行了电生理学研究.
- 向小鼠和患者服用通道阻塞剂.
主要成果:
- 婴儿经历了与同胞性SCN1A(L263V) 突变相关的危及生命的呼吸暂停事件.
- 鼠标模型表现出脑干脱极化之前的呼吸暂停.
- 这种L263V突变对Nav1.1.1.产生了功能的效应.
- 通道阻塞改善了小鼠的呼吸暂停,并减少了患者的事件.
结论:
- 由于大脑干脱极化,SCN1A(L263V) 突变可以导致严重的,危及生命的呼吸暂停事件.
- 这一发现可能与突然婴儿死亡综合征 (SIDS) 的病理生理学有关.
- 管阻塞剂代表了与功能获取SCN1A突变相关的呼吸暂停事件的潜在治疗策略.
相关概念视频
01:28Depolarizing Blockers: Mechanism of Action
1.5K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.5K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:19Depolarizing Blockers: Pharmocokinetics
325
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
325
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
01:26Voltage-gated Ion Channels
8.2K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.2K
01:19Ligand-gated Ion Channels
12.4K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.4K